Clinical trial
An Open Label Study Employing the Topical Immunomodulator Diphenylcyclopropenone in a Stabilized Gel to Treat Cutaneous Metastases
NCT01711684 is registered in ClinicalTrials.gov with Rockefeller University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label Study Employing the Topical Immunomodulator Diphenylcyclopropenone in a Stabilized Gel to Treat Cutaneous Metastases
- Lead sponsor
- Rockefeller University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 16, 2012
- Completion date
- June 22, 2015
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.